Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - STOCK-BASED COMPENSATION
Stock-based Compensation KROS - Keros Therapeutics, Inc.
28.8 M
LAST VALUE
56.64%
2 YEAR CAGR
223.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR